Skip to main content
Caplight Logo









Eclypia

Eclypia

Private
GrenobleHealthcare & Life Scienceshttps://eclypia.com

Last Round

Grant

Nov 9, 2023

Total Funding Raised

$20,000

Company Overview

Eclypia is a medical technology company that develops non-invasive continuous glucose monitoring devices using quantum-cascade laser technology and artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Sensors, Health IoT

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

CGMcontinuous glucose monitoringnon-invasive glucose monitorneedle-free glucosebloodless glucose testingquantum-cascade laserdiabetes managementmedical wearablehealth IoTdigital twinsignal processingmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Eclypia Comparables

Compare Eclypia with similar companies based on industry and business-model similarity.

Eclypia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Afon Technology
85%
Alertgy
84%
PKvitality
84%

Eclypia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 9, 2023

Eclypia Investors

Notable investors and investment history

Eclypia investors
InvestorRounds
Diabetes Center BerneGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 27, 2024

    Monthly visitors grew 331% MoM, from 42 to 181.

  • Nov 9, 2023

    $20K grant received from Diabetes Center Berne.

Eclypia Filings

Explore SEC and related filing metadata, where available.

Eclypia filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Eclypia's valuation, stock price, and market status.

Is Eclypia a public or private company?

Eclypia is a private company.

What is the current stock price of Eclypia?

Eclypia is a private company with no public stock price. Caplight tracks Eclypia's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Eclypia worth (valuation)?

Valuation information for Eclypia is not publicly available.

Can I buy Eclypia stock?

Eclypia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Eclypia's last funding round?

Eclypia's most recent funding round was Grant on November 9, 2023.

Who are the main investors in Eclypia?

Key investors in Eclypia include Diabetes Center Berne.

Will Eclypia IPO soon?

No public IPO plans have been announced for Eclypia.

How can I track Eclypia secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Eclypia's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGrenoble
Employee Range2
Year Founded2021
Last FundingNov 9, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?